Assessment of Insulin Resistance in Women with Polycystic Ovary Syndrome | Chapter 6 | Chemistry and Biochemistry: Research Progress Vol. 8

 

Background: Polycystic ovary syndrome (PCOS) is a complex, multifactorial endocrine disorder affecting 5%- 10% of all women of reproductive age. Insulin resistance (IR), a subnormal target tissue response to a given amount of insulin, is a common feature, but not a diagnostic criterion of PCOS. Due to the severe consequences PCOS exerts on the health and lifestyle of the affected women and IR adding upon those risks, it is of utmost importance to unravel the intricate pathophysiologic cross-link between PCOS and IR.

 

Objectives: The aim of this study is to evaluate the intricate pathophysiologic cross-link between PCOS and IR. To determine if Homeostatic model assessment (HOMA) & Glucose insulin ratio (G:I) can be used as a simple marker to identify PCOS patients at risk for Impaired Glucose Tolerance (IGT) and Type II diabetes mellitus (DM).

 

Methodology: This hospital-based cross-sectional study was carried out in the Department of Biochemistry in collaboration with the Gynaecology & Obstetrics Department, Rajarajeswari Medical College and Hospital, Bengaluru. It was done over a period of 6 months from February 2015 to July 2015. The study was conducted with 85 women, 45 PCOS cases (USG diagnosed) and 40 controls (with regular menstrual cycle) in the age group of 20-40 years. Insulin resistance indices, namely, Fasting Insulin, Glucose insulin ratio (G:I) and Homeostatic model assessment (HOMA) were calculated from the values of Fasting blood sugar and fasting Insulin estimated by Chemiluminiscence immunoassay. Cases and controls were further subdivided based on age as Group I (20-30 yrs) and Group II (31-40 yrs).

 

Results: Fasting blood sugar, fasting insulin, G:I and HOMA were significantly higher (P = 0.0137, 0.0018, 0.0475 and 0.0047, respectively) in cases than in controls. IR was found in 31 out of 45 (68.88%) by the G:I ratio, 26 out of 45 (57.77%) cases by HOMA (<2.5) and 15 out of 45 (33.33%) by Fasting Insulin. There was no significant difference between cases and controls with respect to age, BMI and waist circumference (P = 0.7342, 0.3538 and 0.4841, respectively). When the cases were subdivided, BMI was significantly higher (P 0.0001) in Group II as compared to Group I. IR markers like Fasting insulin, and HOMA were higher in Group I compared to Group II, but not statistically significant.

 

Conclusion: Fasting Insulin, HOMA and G:I can be used as a simple, practical and effective marker to identify PCOS patients who are at risk of Type II DM. The data suggests that patients having Fasting Insulin > 20 IU, HOMA >2.5 & G:I < 4.5 should be closely monitored and considered as high risk for Type II DM. Since this study was cross-sectional, a longitudinal study as a prospective cohort study, is needed to evaluate the predictive value of HOMA and G:I ratios for future development of IGT and type II diabetes in PCOS patients. Additionally, as the research was conducted at a single centre with a small sample size, future studies should involve larger, multicenter cohorts to further explore the intricate pathophysiologic relationship between PCOS and insulin resistance.

 

 

Author(s) Details

Montey Naruka
Department of Biochemistry, Rajarajeswari Medical College and Hospital, Bangalore, India.

 

S. M. R. Usha
Department of Biochemistry, Rajarajeswari Medical College and Hospital, Bangalore, India.

 

B. M. Rupakala
Department of Gynecology and Obstetrics, Rajarajeswari Medical College and Hospital, Bangalore, India.

 

P. Vijaya Lakshmi
Department of Biochemistry, Rajarajeswari Medical College and Hospital, Bangalore, India.

 

Please see the book here :- https://doi.org/10.9734/bpi/cbrp/v8/6710

 

Gut Microbiota as a Modulator of Insulin Resistance: A Review | Chapter 7 | Medical Science: Recent Advances and Applications Vol. 12

 

Insulin resistance is the pivotal pathogenic component of many metabolic diseases, including type 2 diabetes mellitus, and is defined as a state of reduced responsiveness of insulin-targeting tissues to physiological levels of insulin. Recent studies have progressively uncovered aspects of the gut microbiota and how it contributes to the metabolism of key nutrients during IR. The purpose of this review is to examine the role of gut microbiota as a modulator of insulin resistance. Growing evidence indicates that dysbiosis, marked by reduced microbial diversity and an imbalance between beneficial and harmful species, contributes to metabolic dysfunction. Key findings show that a higher Firmicutes-to-Bacteroidetes ratio, the inflammatory action of lipopolysaccharide (LPS), and the beneficial effects of short-chain fatty acids (SCFAs) are central to understanding the link between microbiota and host metabolism. Protective taxa such as Akkermansia muciniphila and Faecalibacterium prausnitzii support metabolic stability, while endotoxin elevation worsens inflammation and insulin resistance. Current therapeutic strategies—including diet modification, physical activity, prebiotics, probiotics, and faecal microbiota transplantation (FMT)—demonstrate potential in restoring microbial balance. Despite these advances, challenges such as interindividual variability and the need for standardised, long-term trials remain. In conclusion, gut microbiota should be regarded not as a passive indicator but as an active therapeutic modulator with strong potential in the prevention and management of insulin resistance.

 

Author(s) Details

Noor Ali Hussein
Babylon Education Directorate, Ministry of Education, Hillah, Iraq.

 

Please see the book here :- https://doi.org/10.9734/bpi/msraa/v12/6442

Interrelation between Diabetes Mellitus and Periodontal Disease | Chapter 7| Medical Research and Its Applications Vol. 9

 The purpose of this chapter is to present scientific evidence for the links between Periodontitis and diabetes with a focus on potential common pathophysiologic pathways including those associated with inflammation, altered host responses and insulin resistance. The pathogenesis of periodontal disease is complex because it reflects a combination of the initiation and maintenance of the chronic inflammatory process by a diverse microbial flora and its numerous bacterial products. The interrelation between diabetes mellitus and inflammatory periodontal disease has been intensively studied for more than 50 years. It seems that there is a reciprocal relationship between these two illnesses: one tends to exacerbate the other, and treating one with care can help treat the other. This relationship is largely mediated by inflammation, which is responsible for the pathogeny and consequences of diabetes mellitus as well as periodontal disease. Conversely, periodontal infection can seriously impair the metabolic control of some diabetic patients. Moreover, treatment of periodontal disease and reduction of oral signs of inflammation may have a beneficial effect on diabetes. Further research is needed to clarify how inflammatory periodontal diseases may affect insulin resistance, glycemic control and the risk of developing other diabetic complications.

 

 

Author(s) Details

A. R. Gharat

Department of Periodontics, Nair Hospital Dental College, Floor no 2, Room no:202, Dr A L Nair Road, Opposite Maratha Mandir, Mumbai Central Pin: 400008, Maharashtra, India.

 

Please see the book here:- https://doi.org/10.9734/bpi/mria/v9/12567F

Role of TNF-α Gene Polymorphism as a Biomarker of Diabetic Nephropathy: A Study among Patients of the Telangana Region, India | Chapter 13 | Medical Science: Recent Advances and Applications Vol. 7

 

Background: Diabetic Nephropathy (DN) is one of the complications in patients with prolonged diabetes. Diabetic nephropathy disorder is most commonly observed in patients with prolonged diabetes, even though other microvascular diseases due to diabetes are also observed. Among the genetic risk factors for DN, TNF-α, an anti-inflammatory cytokine, is proposed to act in a paracrine/autocrine manner and is hypothesised to be associated with insulin resistance. In the current study, the relationship of the G  C variant of the TNF-α gene in patients, associated with other biochemical parameters, with DN was investigated.

 

Aim: The aim of the study was to investigate the inflammatory markers that are involved in the pathogenesis of diabetic nephropathy and could serve as predictive or diagnostic biomarkers.

 

Methods: Demographic factors of the study group were obtained by directly interviewing the study group. Biochemical and diagnostic parameters of the study subjects, plasma glucose levels (fasting and postprandial), and renal function tests (Urea, creatinine) were obtained from the patient’s records. Genomic DNA was extracted from peripheral blood samples of 50 type II Diabetes Mellitus (T2DM) and 50 non-diabetic control subjects.

 

The TNF-α (G    C) polymorphism was analysed using polymerase chain reaction (PCR), followed by restriction fragment length (RFLP) polymorphism analysis.

 

Results: Using statistical analysis, it was possible to correlate demographic parameters with genotyping results, and it was found that 50% patients were GG homozygotes (wild type), 30% were GC heterozygotes, and 20% were CC homozygotes. This suggests that low-grade inflammation could be one of the determinants in the pathogenesis of insulin resistance and T2DM. Most of the patients (80%) in the hospital were not physically active, and these patients had much longer inpatient stays when compared to the patients who were involved in regular physical exercise. The control of inflammatory processes may be useful in the therapy of DN. As there is limited experience available for the inhibition of inflammatory cytokines in DN, it is beneficial to collect and mount evidence for the properties of inflammatory genes.

 

Conclusion: We conclude from this preliminary study that TNF-α G   C genotypes may be a useful biomarker for the early diagnosis of T2DM patients with insulin resistance and nephropathy.

 

Author(s) Details

Kaiser Jamil
Department of Genetics, Bhagwan Mahavir Medical Research Centre, Masab Tank, Hyderabad-500004, Telangana, India.

 

Owaisul Haq
Department of Genetics, Bhagwan Mahavir Medical Research Centre, Masab Tank, Hyderabad-500004, Telangana, India.

 

Zamin Ahmed
Department of Genetics, Bhagwan Mahavir Medical Research Centre, Masab Tank, Hyderabad-500004, Telangana, India.

 

Sindhu Joshi
Mahavir Hospital and Research Centre, Masab Tank, Hyderabad-500004, Telangana, India.

 

Please see the book here:- https://doi.org/10.9734/bpi/msraa/v7/5716

 

Determining the Effect of a High Fructose Diet on Interscapular Brown Adipose Tissue LPL, Cellularity and Lipid Deposition in Aging Congenic Obese-T2DM Rats | Chapter 10 | Contemporary Research and Perspectives in Biological Science Vol. 2

 

The present study aimed to determine the effect of a high fructose diet on brown adipose tissue development in aging congenic obese T2DM rats. The physiological merits of brown adipose tissue (BAT) metabolism as an efficient potential energy buffer that when deficient, may be a contributor to excess fat accretion and to the development of obesity in man and animals.  As such, it offers to be a potential target for therapies that could be developed for its treatment. To determine the effects of dietary fructose consumption on development and cellularity of brown adipose tissue in T2DM, groups of lean and obese SHR/Ntul//-cp rats demonstrating insulin resistance (IR) and heritable T2DM were fed diets containing 54% (w/w) carbohydrate as cornstarch (CS diet) or equal parts CS plus fructose (CSF diet) plus essential proteins, fats, vitamins, minerals, and dietary fiber from one to nine months of age.  The SHR/Ntul//-cp rat is a congenic animal model in which the only genetic difference between the phenotypes is the epigenetic inheritance and natural expression of the obese (-cp) trait, which is distinct from dietary, toxicologic, or pharmacologic factors and is accompanied by the development of chronic insulin resistance (IR) and non-insulin-dependent diabetes (T2DM) shortly after weaning in the obese phenotype.

 

The effects of this study indicate that final weight gain and Interscapular brown adipose tissue mass and cellularity are significantly greater in the obese than in the lean phenotype. In addition, the effects of a high fructose diet resulted in only modest increases in body weight gain, and in differential effects on IBAT cellularity and cell lipid content. Weight gain of obese >> lean and was greater when fed the CSF than the CS diet in both phenotypes; Interscapular brown adipose tissue (IBAT) mass of obese >> Lean and was similar in both phenotypes.  IBAT Mass: Body weight of Obese >> lean, and trended greater in lean CSF vs CS but less in Obese CSF vs CS. IBAT cell size and lipid content of obese >> lean, and the CS vs CSF diet was similar in lean but decreased in the obese phenotype. IBAT cell number of obese >>> lean, while IBAT cell number of lean CSF > lean CS, but IBAT cell number of obese was similar with both diets.  Lipoprotein lipase activity (LPL) of lean >> obese and trended to be greater with the CSF than the CS diet in both phenotypes and IBAT tissue lipid content of obese >> lean with a trend toward CSF > CS in both phenotypes. These results indicate that IBAT development occurs via hyperplasia and hypertrophy in the Obese phenotype of this strain and that long term consumption of the high Fructose diet enhances IBAT cellularity in the lean phenotype while the IBAT cellularity was maximally enhanced by both diets in the obese phenotype.

 

These results further indicate that the impact of long-term consumption of a high fructose diet throughout much of the natural lifespan impacts the development of IBAT mass and cellularity differentially in the lean and obese+T2DM phenotype, likely at least in part due to contributions of longstanding IR in the obese+T2DM animals. Because IR is known to impede cellular glucose uptake in isolated brown adipocytes as an essential process in the expression of cellular thermogenic responses, any potential mechanisms to override or bypass the process or decrease the magnitude of IR would be presumed to exert a beneficial effect. Fructose may increase the potential for the expression of IBAT development and the expression of non-shivering thermogenesis in response to changes in food and environment because it can enter tissues independently of insulin activities, for example, through the GLUT1 and GLUT5 transporters. Nevertheless, in the current investigation, it was discovered that overall fructose consumption was neither significantly advantageous nor ameliorative in resolving crucial parameters of brown adipose tissue expression as contributors to the development of obesity in the obese+T2DM phenotype.

Author (s) Details

Orien L Tulp
Colleges of Medicine and Graduate Studies, University of Science Arts and Technology, Montserrat, BWI MSR1110 and Einstein Medical Institute, N. Palm Beach, FL, 33408, USA.

 

 

Please see the book here:- https://doi.org/10.9734/bpi/crpbs/v2/2210

Gastric Emptying Dynamics and Glycemic Responses in Obese and Diabetic SHR/N-cp Rat Models: Implications for Understanding Type II Diabetes | Chapter 13 | Medical Science: Trends and Innovations Vol. 12

Obesity and overweight conditions, separately or in concert with Type II Diabetes mellitus (T2DM), are now occurring globally with an alarming incidence throughout much of industrialized society. Disordered gastric physiology is a common observation in diabetes, including processes of both rapid emptying early in T2DM and in gastroparesis in later stages of both T2DM and Type 1, insulin-dependent diabetes. The purpose of the present study was to characterize the expression of the obese and obese+T2DM traits in the development of T2DM and its impact on gastric emptying and glycemic parameters when reared under identical conditions of diet and environment. To determine the characteristics of gastric emptying in lean, obese, and obese diabetic rats, measures of oral glucose tolerance (OGT) were determined, and glycemic parameters of obesity and type II diabetes (T2DM) were measured. The study was approved by the Institutional Animal Care and Use Committee. Fasting plasma Insulin, amylin, and markers of insulin resistance were greater in obese than in lean littermates and increased further in both young and old obese+T2DM rats. The oral glucose tolerance and glucose areas under the curve (AUCglc) were modestly impaired in obese LA/Ntul//-cp rats, with only a modest increment in the early phase (0 to +30 min post ingestion) of luminal glucose uptake. The OGT in obese+T2DM rats was markedly impaired, with additional progression in aging. The fractional AUCglc from 0 to+30 minutes was significantly increased in the obese+T2DM rats, and the acceleration in initial glycemic response of OGT was increased 6-fold in young T2DM rats and remained greatly elevated thereafter. The initial and late post-absorptive glycemic phase of the OGT in old obese individuals was greater than in younger obese T2DM. These results are consistent with epigenetic expression of obesity and obesity+T2DM and with dysregulation in the kinetics of gastric emptying analogous to Dumping Syndrome or Sirt1 dysregulation in the young obese-T2DM phenotype of the SHR/Ntul//-cp rats and the neurologic onset of gastroparesis in old T2DM SHR/Ntul//-cp rats. The result of this study indicates that the aberrant glycemic responses to a standard OGT in obese and obese-T2DM rats were consistent with accelerated gastric emptying in young obese+T2DM rats, in addition to glycemic responses consistent with the onset of gastroparesis in combination with insulin resistance in older obese+T2DM rats.  Thus, the Obese+T2DM rat is a useful model for the further investigation of the pathophysiology of obesity and T2DM as it occurs in man and animals.

 

Author (s) Details

 

Orien L Tulp
Colleges of Medicine and Graduate Studies, University of Science, Arts and Technology, USA.

 

Please see the book here:- https://doi.org/10.9734/bpi/msti/v12/4872

Ceramide Synthase Isoforms and Insulin Resistance: A Molecular Perspective | Chapter 12 | Achievements and Challenges of Medicine and Medical Science Vol. 2

The review analyzes the literature data that forms the basis for the "ceramide-centric" view of insulin resistance pathogenesis and obesity-associated diabetes mellitus type 2. The results of recent independent studies have shown that normal sphingolipid metabolism is one of the most important conditions for maintaining glucose homeostasis in the body. The lipid analysis of adipose tissue, skeletal muscles and liver in rodents with experimental obesity, as well as biopsic specimens of diabetics, indicate the high pathogenicity of specific ceramide family members. Analysis of the clinical material and the results of model experiments showed that increased expression of the isoenzyme CerS-6 positively correlated with the degree of resistance to insulin. The degree of pathogenicity is determined by the length of the acyl chain included in de novo synthesized ceramide with the involvement of one of the six ceramide synthase isoenzymes. Selective inhibition of the ceramide synthase-6 isoenzyme to reduce the tissue level of the most pathogenic C16:0-ceramide may be a promising approach for correcting insulin resistance. The creation of a specific inhibitor of CerS-6 will allow selectively to reduce the tissue content of C16:0-ceramide, which, apparently, may contribute to the development of a new direction of pathogenetically grounded pharmacological correction of obesity-associated insulin resistance.

 

Author (s) Details

Kuzmenko Dmitry Ivanovich
Department of Biochemistry and Molecular Biology, Clinical Laboratory Diagnostics of the Siberian State Medical University, SSMU, 634055, Tomsk, Moskovsky trakt, 2, Building 2. Russia.

 

Klimentyeva Tatyana Konstantinovna
Department of Biochemistry and Molecular Biology, Clinical Laboratory Diagnostics of the Siberian State Medical University, SSMU, 634055, Tomsk, Moskovsky trakt, 2, Building 2. Russia.

 

Please see the book here:- https://doi.org/10.9734/bpi/acmms/v2/2795

 

An Overview of T2DM: A Model of Diabetes Mellitus | Chapter 9 | Disease and Health: Research Developments Vol. 2

A large part of the population suffers from a disorder in the metabolism of energy-rich substances (glucose, fats or proteins), diabetes mellitus (DM). A simple model allows us to understand the aetiology, pathophysiology and basic methods of modern treatment of the disease.

In many cases, the disease is caused by a malfunction of hormones, especially insulin.  More than 10% of cases of DM are caused by an absolute or relative lack of insulin, mainly due to an autoimmune process that destroyed insulin-producing cells - type 1 diabetes (DM1) or in the final stages of other types of diabetes due to terminal failure of regulatory mechanisms. In rare cases, DM is due to a decrease in all the effects of insulin - real insulin resistance or due to a real lack of insulin (Mody 2 for example). Metabolism takes place in cells. Hundreds of different enzymes affect the metabolism of energy-rich substances. Each of them can be damaged. However, it seems that the main cause of the disease is an inappropriate lifestyle, which secondarily damages the regulatory systems. This is the cause of type 2 diabetes (DM2). A high energy input/low energy expenditure (HEILEE) lifestyle is not compatible with a human genetic background. Deviations in glucose metabolism initially arise as a feedback, cellular defence against energy-rich substances overload, and are therefore reversible. If energy surplus persists for a long time, irreversible malfunctions occur. Untreated DM1 is characterized by intracellular starvation and lack of ATP. DM2 is characterized by “cellular overeating”. There gradually develop serious collision between intracellular regulatory mechanisms (AMPK, CD36-SR-B2, controlled by the amount of ATP, glycogen, lipid and other energy-rich substances), and cascades of hormone second messengers. Insulin deficiency and insulin resistance in DM2 are emphasized above all today. The question, of which of these disorders (or obesity) is the first, provoking the development of DM2, is discussed in the literature. Neither of them – both are the consequence of a chronic energy surplus. Chronic hyperinsulinemia is present in the early stages of the disease. Insulin ensures a high transfer of glucose from the blood to the tissues in obese people, but it is unable to maintain an adequate level of glucose in the blood. The disease is characterized by a special disorder - “Insulin uncoupling", a defect when there is a simultaneous increase in some effects and a decrease in other effects of the hormone. The ability of insulin to ensure anabolic processes is preserved. The ability to form visceral fat stores or the ability to retain sodium is increased. Hormone synthesis in DM2 gradually decreases, and the patients may become fully dependent on external insulin administration.

What therapy results from the above-mentioned principles? The goal of our efforts should be the complete restoration of the metabolism of energy-rich substances, carbohydrates, fats and other substances. Patients who are unable to synthesize insulin need this hormone (its analogues), in adequate amounts depending on needs. Patients who produce insulin but are unable to release it sufficiently will be optimally treated with sulfonylurea derivatives (MODY 2, MODY 12). Patients who are unable to release insulin depending on food intake will be optimally treated with GLP1 analogues, and incretins. The basic medical treatment for patients suffering from DM 2 reduces energy intake. The anorexic effect of GLP1 agonists is beneficial.  Metformin reduces the metabolism efficiency. This drug increases the amount of glucose processed anaerobically. Subsequently, metabolism in the Cori cycle causes significant energy losses. Currently, there are even drugs available that allow the removal of unnecessarily received energy by removing glucose from the body via urine-gliflozins. Insulin administration is appropriate to restore adequate blood glucose levels. Long-term administration of high doses of insulin is nevertheless not the optimal therapy for early-stage DM2.  A return to a lifestyle that corresponds to the conditions under which the human organism evolved - with limited food intake and relatively high energy expenditure through physical exercise- could prevent the population from developing diabetes mellitus.

 

Author (s) Details

 

Kubat K
PN Horni Berkovice, Plesivecka 912/10, 41201 Litomerice, Czech Republic, Europe.

 

Please see the book here:- https://doi.org/10.9734/bpi/dhrd/v2/3640

Impact of Aging and Obesity on Insulin Parameters, T4/T3 Ratios, Metabolic Rates, Sirtuins and Longevity in Congenic LA/Ntul//-cp (Corpulent) Rats | Chapter 2 | Medical Science: Trends and Innovations Vol. 5

The integrated effects of aging on thyroidal function and other hormonal and regulatory aspects of metabolism are important elements in various aspects of aging and longevity. Changes in thyroidal activity occur in aging, where they typically exhibit a U-shaped curve for plasma TSH concentrations, with variable responses in other parameters of thyroidal function and peripheral physiological actions and their pathophysiologic sequelae. The LA/Ntul//-cp rat strain, developed from a cross between a Koletsky Rat and an NIH longevity-prone LA/N strain of unknown origin exhibits one of the longest life spans of the various rodent strains that express a trait for early onset obesity in association with impairments in sympathetic and thyroidal components of non-shivering thermogenesis, insulin resistance and energy metabolism. To determine the effects of aging and obesity from adolescence through much of the projected lifespan of the obese phenotype, groups of congenic lean and obese female LA/Ntul//-cp rats were studied from 4 until 24 months of age denoting this design comprised the projected lifespan of the obese phenotype. Measures of Resting Metabolic rates (RMR), fasting plasma insulin and glucose, T3, T4, the plasma half-life of T4, and computation of T4/T3 ratios were determined as an indication of the capacity for deiodination of T4 to T3 in peripheral tissues and its cumulative effects on RMR. Body weight of obese >>> lean at all ages studied. Plasma Insulin was significantly elevated in the obese phenotype, and decreased with advancing age, while plasma glucose remained within the normal fasting range in all rats of both phenotypes. RMR of lean > obese at all ages studied and decreased with advancing age in both phenotypes. Liver T4-5’ deiodinase activity of lean > obese at all ages studied. Plasma T4/T3 ratios decreased with aging in both phenotypes, with the greatest decrease in the obese phenotype. The T1/2 of 131I-T4 was over 40 % longer in the obese phenotype littermates at 4 months of age (p=< 0.01). These results suggest that conversion of T4 to T3 in peripheral tissues in association with attenuation of hyperinsulinemia contributes to decreases in RMR with aging and is further decreased in the obese phenotype, thereby decreasing the quantifiable availability of tissue T3 mass for thyroidal actions at the genomic level, including decreases in harmful reactive oxygen species (ROS) and other entities as products of intermediary metabolism. Thus, the progressive decreases in plasma insulin and deiodination-mediated activation of T4 may represent a longevity attribute via decreases in resting metabolic rates, and in an associated attenuation of free radical generation and other metabolic factors of aging and longevity in this strain.

 

Author (s) Details

Orien L Tulp
Colleges of Medicine and Graduate Studies, University of Science Arts and Technology, Montserrat, British West Indies.

 

Please see the book here:- https://doi.org/10.9734/bpi/msti/v5/4161

Urotensin II Levels is Associated with Insulin Resistance in Patients with Gestational Diabetes Mellitus | Chapter 2 | Advancement and New Understanding in Medical Science Vol. 2

Background: Gestational diabetes mellitus is glucose intolerance of varying degrees with onset or first detection during pregnancy, it can cause long and short-term morbidities in both the mother and the child, such as shoulder dystocia, preeclampsia, and high blood pressure. The most powerful endogenous vasoconstrictor peptide, urotensin II, and its receptor are involved in the etiology of gestational diabetes mellitus. The considerable decline in insulin sensitivity that occurs late in pregnancy reveals the lower insulin sensitivity that occurs before pregnancy.

Aim: The aim of the study is to see if there is a link between Urotensin II levels and insulin resistance in pregnant women with gestational diabetes.

Method: This is a case-control study, conducted in the obstetrics and gynecology department at Baghdad Teaching Hospital from the first of January 2019 to the end of December 2019. A sample of 80 pregnant women participated in the study fulfilling inclusion criteria. 40 of them were diagnosed with gestational diabetes mellitus by (2 hours 75 gm. Oral glucose tolerance test) and 40 women as a control group. The analysis was done by using the Statistical Package for Social Science (SPSS) program, version 23 for qualitative variables.

Results: The mean age of the gestational diabetes mellitus group was 29.8±6.9 years and control was 29.7±6.6 years with no significant differences. The study showed a highly significant increase in Insulin, fasting blood glucose, and Homeostatic Model Assessment for Insulin Resistance (HOMA-IR), of the GDM group than that in the group without disease. A significant difference was found regarding high -  sensitivity C-reactive protein hs-CRP (p=0.004). The level of Urotensin II in subjects with gestational diabetes was (109±33.22) highly was higher than that in healthy subjects (78±22.6). There is a positive correlation between circulating Urotensin II levels with fasting insulin and HOMA-IR. While a negative correlation was found with fasting blood glucose.

Conclusion: The level of UII was found to be raised in gestational diabetes pregnant women. We also discovered that circulating levels of UII were greater in women with GDM than in controls. Insulin resistance was observed to be greater in pregnant women with GDM in comparison with controls.

Author(s) Details:

Najmah M. Meran,
Obstetrics and Gynecology Department, College of Medicine, University of Baghdad, Baghdad, Iraq.

Farah Abdul Salam Hussein,
Obstetrics and Gynecology Department, Baghdad Teaching Hospital, Baghdad, Iraq.

Please see the link here: https://stm.bookpi.org/ANUMS-V2/article/view/13088

Determining the Influence of the Ketogenic Diet on Metabolic Syndrome | Chapter 3 | Novel Research Aspects in Medicine and Medical Science Vol. 6

 Metabolic disease (MetS) is a constellation of extreme blood pressure, hyperglycemia, obesity, and dyslipidemia. Its appearance makes the patient more likely for cardiovascular events. Its predominance has been recorded as 11%–41%. Metabolic syndrome is a clustering of not completely three of the following five medical environments: abdominal corpulence, high blood pressure, extreme blood sugar, extreme serum triglycerides, and depressed serum high-bulk lipoprotein (HDL). Metabolic syndrome is guide the risk of developing heart failure and type 2 diabetes. The incidence of corpulence, the metabolic syndrome, and its pathophysiologic results is on the rise general and has reached unacceptable levels in the majority of Westernized and economically advanced organizations. Obesity, hypertension, non-insulin dependent diabetes, and hyperlipidemia accompanying reduced skin high bulk lipoprotein concentrations are often associated comorbidities of metabolic disease. Additionally, the condition is frequently followed with a ordinary finding of hyperinsulinemia and insulin resistance conventional of high-hydrogen diets. The incorporation of the insulin careful ketogenic diet as a dietary strategy for the situation of metabolic syndrome concede possibility bring about betterings in insulin action and substrate exercise in peripheral tissues with not completely a partial alternatively significant determination of the syndrome. Thus, the ketogenic diet in addition to reworking toward a healthy behavior and pharmacologic therapies have existed explored as potential mechanisms to resolve the pathophysiologic result of obesity and metabolic disease and their impact on the childbirth of healthcare. Metabolic syndrome (MetS) is a condition delineated as a clustering of risk factors that is to say strongly guide obesity, myocardial infarction, and diabetes. It has recently been supposed that the global predominance of MetS has reached epidemic levels containing the U.S.A., where it has existed estimated that 20% to 25% of the adult global community meets the diagnostic test for MetS, which grant permission be established when at least three of the five basic risk factors are present. The risk determinants include a big waistline (abdominal or instinctive obesity), extreme plasma triglyceride levels, depressed plasma HDL cholesterol concentrations, raised blood pressure, and fasting hyperglycemia. The standard and most direct treatments for MetS to date have happened incorporation of behavior changes, with dietary interferences being one of the main effective behavior modifications utilized to treat two together obesity and MetS. The Ketogenic Diet (KD) is one digestive intervention that concede possibility have the potential to improve MetS risk determinants. Historically, one of the primary uses of the KD has happened to treat epilepsy, nevertheless, there is solid evidence that it may also help to help other environments and illnesses, containing obesity and MetS. Despite this potential, sure dietary misconceptions grant permission have prevented or restricted further research on the KD applications to pressure control and use of the KD, particularly the emergence of the nationwide dietary directions that have now advanced a low-fat, extreme-carbohydrate diet for several decades. The purpose concerning this paper is to conduct a review of the information regarding MetS, the KD, and the associations of the KD as a treatment for obesity and MetS. Existing research is orderly reviewed concerning the KD’s potential to address MetS and MetS risk factors. The results of the review signify the validity of the diet and the need for further research on the KD and its potential to address the benefits, potential risks and dispassionate efficacy of the KD on lowering the pathophysiologic sequalae of obesity and MetS. MetS = Metabolic Syndrome, KD = ketogenic diet, KB = ketone frames, including metabolic shreds acetoacetate (AcAc),3-beta-hydroxybutyrate (3HB), and acetone, PSMF = Protein Sparing Modified Fast, HDL, HDL-C= plasma extreme density cholesterol lipoprotein, LDL, LDL-C = reduced density cholesterol lipoprotein, TG, TRIG = body tissue triglycerides, CRP = C-reactive protein, GLUT4 = Glucose Transporter 4, and insulin- linked natural entity, ATP = Adenosine tri-phosphate, a extreme energy phosphate, CCK = cholecystokinin, CR = calorie limited diet, LFD = low fat diet, LCKD = reduced calorie ketogenic diet, BP = blood pressure; SBP = systolic blood pressure; DBP = diastolic ancestry pressure, A(1c) = glycosylated hemoglobin part, NHLBI = National Heart, Lung and Blood Institute of the National Institutes of Health.

Author(s) Details:

Michael E. Anderson,
Colleges of Medicine and Graduate Studies, University of Science, Arts and Technology, Montserrat, MSR1110, British West Indies.

Orien L. Tulp,
Colleges of Medicine and Graduate Studies, University of Science, Arts and Technology, Montserrat, MSR1110, British West Indies.

Please see the link here: https://stm.bookpi.org/NRAMMS-V6/article/view/12140

A Study of the Correlation between Pulmonary Function Test and Different Components of Metabolic Syndrome in South Indian Patients with Metabolic Syndrome | Chapter 13 | New Advances in Medicine and Medical Science Vol. 6

 This episode aims to determine the connection between Metabolic syndrome and Pulmonary function in cases with metabolic disease as well as association 'tween different parts of metabolic syndrome concerning impairment of pulmonary function test.Metabolic syndrome has happened linked to pulmonary dysfunction. However, skilled is inadequate data, specifically in Indians, on the connection accompanying individual components of metabolic condition and the overall effect on multiple components of pulmonary function.This cross-divided study was carried out in the Department of General Medicine at Bangalore Medical College and Research Institute, Bangalore, India. The study was comprising 50 subjects with metabolic disease.An unpaired t-test and Pearson's prejudiced correlation cooperative were used to assess the relationship 'tween the various components of the metabolic syndrome and the pulmonary function tests, which were executed to all of the individuals.Females revealed moderately negative meaningful correlations between compulsory vital competency (FVC) and systolic blood pressure (SBP), diastolic blood pressure (DBP), abstaining blood sugar (FBS), triglyceride (TG),midriff circumference (WC) and bulk mass index (BMI) whereas a definite weak non-meaningful correlation was seen 'tween FVC and High-densitylipoprotein cholesterol (HDLC), while no specific relation was establish with forced expiratory capacity in one second (FEV1).In men, there was a negative, moderately important association 'tween FVC and FBS, but a strong, helpful, significant link between FVC and WC and betwixt FVC and BMI. FEV1 and WC had a negative, marginally important connection, as did FEV1 and BMI.Our study erect that FBS and WC significantly diminished FVC in both sexes, while additional metabolic syndrome factors had a kind of significant influence on FVC and no effect on FEV1, displaying a restrictive pattern of pulmonary function derangement. Insulin fighting could likely be a ruling contributing determinant. In order to determine if there are direct or unintended processes via that insulin resistance could impact pulmonary function, supplementary research with more generous sample numbers is required.

Author(s) Details:

Sudha Karbari,
Bangalore Medical College and Research Institute, Bangalore, India.

Please see the link here: https://stm.bookpi.org/NAMMS-V6/article/view/10994

BMI and Circulating Adipocytokine Markers in Insulin Resistance Females with Type 2 Diabetes | Chapter 1 | Novel Aspects on Pharmaceutical Research Vol. 3

 The present study determines to assess by means of what Insulin Resistance females accompanying Type 2 diabetes' levels of resistine, fasting blood glucose, and adiponectin distinguished to their BMI. Obesity has emerged as a community health crisis in many peoples including Sudanese. Adipose fabric produces several adipokines, one of bureaucracy is adiponectin which has engaged much attention by way of its antidiabetic and antiatherogenic belongings. A total of 205 Sudanese women betwixt the ages of 35 and 64 were recruited to participate in this explanatory cross-sectional study. Adiponectin and resistine concentrations were contingent upon ELISA Kits, and plasma levels of level of glucose in blood were determined by utilizing the particle-enhanced immunoturbidimetric assay order Cobas C-311®.  Observed from these results significant dissimilarity between the resources of fasting level of glucose in blood (FBG), adiponectin, resistine and BMI classified in accordance with WHO body mass index categorization (underweight, active weight, corpulent, obesity and dissociate obesity). In this study, the results show powerful negative Correlation between the levels of serum Adiponectin and Fasting Blood Glucose. (P.worth = 0.013, r = -7.9), Adiponectin and Resistine. (P.value = 0.019, r = -6.6). In the opposite strong certain Correlation between the levels of antitoxin Resistine and Fasting Blood Glucose. (P.value = 0.015, r = 6.0). Observed from this results negative Relationship between the mean of BMI distinguished with the record of the patient/ years.The study told that BMI had an impact on the levels of adipocytokines and raised the risk of insulin resistance in women with Type 2 diabetes by increasing the level of resistin, abstaining blood glucose, and lowering adiponectin in various groups top-secret according to WHO frame mass index (BMI) classification.

Author(s) Details:

Salah Eldin Omar Hussein,
Department of Medical Laboratory Sciences, College of Health Sciences, Gulf Medical University, Ajman, UAE and University of Sciences and Technology, Sudan.

Please see the link here: https://stm.bookpi.org/NAPR-V3/article/view/10876

Glucocorticoid Ablation Attenuates Insulin Resistance and Improves Glucose Tolerance in the Obese LA/Ntul//-cp RAT | Chapter 10 | New Advances in Medicine and Medical Science Vol. 2

 The counterregulatory belongings of glucocorticoids and insulin that commonly happen in obesity result in the growth of insulin resistance and injured glycemic responses to dietary carbohydrates. Two together adipose fabric and skeletal power are dependent on insulin actions to cause success glucose rude answer, and the combined hormonal effects enhance disordered processes of minimum energy requirement in insulin dependent tissues that mainly correspond to the magnitude of insulin fighting. To determine the belongings of glucocorticoid inhibition on usual insulin-mediated glycemic processes in obese rats, groups (n=6 -12 rats/phenotype) of usually reared durability-prone congenic lean and obese mammals were fed a Purina food diet from 6 to 9 weeks of age, and overfill with the Chow diet plus a very palatable restaurant diet from 9 to 12 weeks of age. The congenic LA/Ntul//-cp rat strain articulates the obese characteristic soon after detaching but remains glucose prejudiced but non-diabetic thereafter. Subgroups of corpulent animals were subjected to reciprocal adrenalectomy (ADX) at 6 weeks of age to away glucocorticoid contributions to glycemic limits. At 6, 9, and 12 weeks of age, each treatment group realized weight gain (WG) and sweet liquid tolerance (OGT). At 6 and 9 weeks of age on the food diet, WG on ADX-obese rats was equivalent to that of their lean littermates, but was doubly that of their lean littermates from 9 to 12 weeks of age. following 30 to 60 record, OGT responses and the area under the OGT curve were injured but not diabetic in obese mammals of all ages, and reverted to those of lean rats following ADX. At 12 weeks of age, the insulin to sweet liquid ratio (I:G) was logical with insulin opposition in obese rats but not in ADX-obesity or lean rats. At 9 and 12 weeks adult, ADX led to the normalization of OGT and glycemic indications in the obese phenotype. These verdicts support normalizationof typical insulin-mediated parts of glycemic parameters and sweet substance uptake in peripheral tissues following glucocorticoid devaluation due to use of congenic obese rats, and plan that the counterregulatory effects of insulin and glucocorticoid hormones can be contributory to the impaired glycemic reactions in the obese phenotype of the LA/N//-cp (fat) rat and are consistent accompanying a receptor-mediated aspect in the development of insulin fighting and glucose uptake in minor tissues commonly guide the early development of obesity in this place strain.

Author(s) Details:

Orien L. Tulp,
University of Science Arts and Technology, Montserrat, BWI, University of Health and Humanities, Virgin (BVI) and the Einstein Medical Institute, Florida USA.

Aftab R. Awan,
University of Science Arts and Technology, Montserrat, BWI, University of Health and Humanities, Virgin (BVI) and the Einstein Medical Institute, Florida USA.

George P. Einstein,
University of Science Arts and Technology, Montserrat, BWI, University of Health and Humanities, Virgin (BVI) and the Einstein Medical Institute, Florida USA.

Please see the link here: https://stm.bookpi.org/NAMMS-V2/article/view/10628

Thyroid Dysfunction and Diabetes Mellitus: A Complex Interdependent Interaction | Chapter 2 | Research Developments in Medicine and Medical Science Vol. 7

 Thyroid ailments and diabetes mellitus are, arguably, among the ordinary endocrine disorders worldwide. Diabetes mellitus (DM), a common endocrine metabolic disorder, is an main cause of morbidity and death worldwide. Thyroid dysfunction has been commonly encountered in diabetic victims with hypothyroidism being the most accepted type of dysfunction. Diabetics have a higher predominance of thyroid disorders when compared with the accepted population. Alteration in thyroid function confuses the management of diabetes mellitus and its problems. Thyroid hormones contribute to the managing of carbohydrate metabolism and pancreatic function, and in another way, diabetes affects thyroid function tests to changeable extents. This chapter demonstrates the significance of recognizing this cooperative relationship between thyroid ailment and diabetes, which will help allure early diagnosis and treatment and guide clinicians on the optimum screening and administration of these conditions.

Author(s) Details:

Tejinder Singh,
Department of Biochemistry, Govt. Medical College Amritsar, Punjab, India.

Jaswant Kaur,
Department of Biochemistry, NC Medical College & Hospital, Panipat, Haryana, India.

Jaspreet Kaur,
Department of Physiology, Adesh Medical College, Bathinda, Punjab, India.

Mridula Mittal,
Department of Physiology, Adesh Medical College, Bathinda, Punjab, India.

Vishal Gupta,
Department of Community Medicine, GGSMCH, Faridkot, Punjab, India.

Please see the link here: https://stm.bookpi.org/RDMMS-V7/article/view/10068

AMP-kinase is the Main Target of Metformin in Regulating Type 2 Diabetes | Chapter 8 | Research Highlights in Disease and Health Research Vol. 2

 AMP-mobilized protein kinase (AMPK) is a major cellular manager that is activated when natural energy levels are low and provokes glucose rude answer in skeletal muscle, oily acid oxidation in adipose and added tissues, and decreases hepatic glucose production. The incitement of AMPK's metabolic effects, particularly the metabolic shift from fat combination to fat oxidation and its capability to promote power glucose uptake, proper to be beneficial in things with insulin resistance and/or type 2 diabetes. Since, AMPK is a principal regulator of energy equilibrium, it has been considered expected an important therapeutic aim for controlling human ailments including the metabolic syndrome. AMPK equips to be the key target substance causing chemicals to split into simpler substances of metformin to reduce plasma sweet liquid levels. Also, thiazolidinediones (TZDs) and 2-deoxyglucose have been shown expected indirect activators of AMPK. In this review, we discuss only the likely underlying devices of metformin's miraculous strategies (in threatening plasma glucose level) at the microscopic level, which will also specify an updated reference for the clinicians and analysts.F

Author(s) Details:

Rashidul Haque,
Department of Nephrology, Government Medical College & Superspeciality Hospital, Aurangabad, Maharashtra, India.

Sultana Rajia,
Department of Nephrology, Government Medical College & Superspeciality Hospital, Aurangabad, Maharashtra, India

Please see the link here: https://stm.bookpi.org/RHDHR-V2/article/view/9616

Beneficial Role of Adiponectin in Reproduction| Chapter 8 | Current Topics on Chemistry and Biochemistry Vol. 7

 Adipocytokines are fatty fabric derivative biologically alive proteins. These are fat hormones that play critical role in generative any branch of natural science. The equalized aggregation of the adipocytokines organizes complex elaborate pathways that link insulin fighting and generative process. Adiponectin, an adipocyte derived adipocytokine is deliberate as the new manager of female generative arrangement. Its finding had managed to the broad analyses of biological function of Adiponectin that augments insulin sense, skipped to the developing function on redness and human duplication. An twisted interplay of the adipocytokines ensues right from adolescence to pregnancy, accompanying more affect ovulatory process.

Author(s) Details:

K. A. Arul Senghor,
Department of Biochemistry, SRM Medical College Hospital and Research Centre, SRM Institute of Science and Technology, SRM Nagar, Kattankulathur – 603203, Kanchipuram, Chennai, Tamil Nadu, India.

S. Meera,
Department of Biochemistry, SRM Medical College Hospital and Research Centre, SRM Institute of Science and Technology, SRM Nagar, Kattankulathur – 603203, Kanchipuram, Chennai, Tamil Nadu, India.

V. M. Vinodhni,
Department of Biochemistry, SRM Medical College Hospital and Research Centre, SRM Institute of Science and Technology, SRM Nagar, Kattankulathur – 603203, Kanchipuram, Chennai, Tamil Nadu, India.

M. Anuradha,
Department of Biochemistry, SRM Medical College Hospital and Research Centre, SRM Institute of Science and Technology, SRM Nagar, Kattankulathur – 603203, Kanchipuram, Chennai, Tamil Nadu, India.

Please see the link here: https://stm.bookpi.org/CTCB-V7/article/view/9230

Low Carb High Protein Diets to Treat Insulin Resistance in Patients with Obesity and/or Type 2 Diabetes Mellitus| Chapter 7 | Current Overview on Disease and Health Vol. 7

Low carbohydrate, high protein diets have been prescribed since 1797 and are taken seriously by many researchers and health professionals, though the diet is still met with skepticism in mainstream dietetics and medicine. Insulin resistance (IR) is caused by a series of physiological events that begin with hyperfagia and progress to a positive energy balance and weight gain. Because of their high insulin levels, patients with IR gain weight easily and have difficulty losing weight on diets with a normal carbohydrate content. A diet for patients with IR must therefore tackle this problem to make weight loss possible. Recently, developments in the management of type 2 diabetes mellitus incline towards lowering of carbohydrate intakes to put T2DM in remission, making it even more important to look carefully at the evidence, because patients may benefit from it in a direct way. This review discusses the evidence on the diet's short and long-term effects, effects on comorbidities, and differences from the Mediterranean diet. A search was carried out in Pubmed for articles of obesity management, IR, low carb/high protein diets and weight loss combined with comorbidities, several nutrients and the Mediterranean diet between 1995 and July 2017. In weight loss management, the outcomes were compared to patient observations from dietary practice.

Waist circumference measurement makes diagnosis simple. The diet should be low in carbohydrates and rich in protein without inducing ketosis; each person's needs for energy and macronutrients should be considered. Focusing on unsaturated fats, fat is neither too high nor excessively low. Magnesium, iodine, and vitamin D intake must be at recommended levels. Alcohol consumption is not included in the diet's initial phase. Exercise is a crucial component of treatment because it builds endurance and resistance. Patients taking type 2 diabetes medication need to carefully monitor their food and glucose levels. Low carbohydrate/high protein diets should be considered as a serious treatment option for all obese patients with and without comorbidities. They should be administered by specialized dietitians as part of a multidisciplinary team. Low carbohydrate/high protein diets should be considered as a serious treatment option for all obese patients with and without comorbidities. They should be administered by specialised dietitians working in a multi-disciplinary team.

Author(s) Details:

Elisabeth Govers,
Dutch Knowledge Centre for Dietitians on Obesity, Amsterdam, The Netherlands and European Specialist Dietetic Network on Obesity, European Federation of the Associations of Dietitians (EFAD), Naarden, The Netherlands and Nutrition Working Group, European Association for the Study of Obesity (EASO), Teddington, UK.

Please see the link here: https://stm.bookpi.org/CODH-V7/article/view/9081

Value of Insulin Resistance Indices for Detecting Insulin Resistance in Polycystic Ovarian Syndrome Patients: A Case-control Cross Sectional Study| Chapter 1 | Current Overview on Disease and Health Research Vol. 8

 Polycystic Ovarian Syndrome (PCOS) is from an increased ovarian and androgen birth control method secretion. Insulin opposition is thought expected a high risk in PCOS victims (IR). IR is a symptom of PCOS that involves impaired hydrogen tolerance and raised insulin production. The HOMA-IR test measures level of glucose in blood and insulin levels to assess insulin opposition. Other indices for deciding IR are the quantitative insulin sense check index (QUICKI) and the McAuley index. In order to ascertain the IR with PCOS participants, the HOMA-IR, QUICKI, and McAuley index were secondhand in this study. There were 62 colleagues in this case-control cross-divided study who categorized in age from 20 to 40. They were split into two groups, Group A, which contained 31 healthy, age-doubled female participants, and Group B, that included 31 PCOS subjects who had existed analyzed using Rotterdam tests. Utilizing HOMA-IR, QUICKI, and the McAuley index, IR was evaluated similarly the examined biochemical dossier. Student t-test, ROC curve, and bivariate regression reasoning were carried out for mathematical analysis. This study establish that a rise in BMI was associated with an raised probability of cultivating PCOS. Fasting glucose, insulin, and lipid profiles—all sustain HDL-C—were all noticeably greater in PCOS patients. The HOMA-IR was severely elevated when in fact the QUICKI and McAuley's indexes were significantly curbed in PCOS patients, displaying a higher risk of IR growth. The chance of developing IR in PCOS inmates increases by 86.25% when HOMA-IR levels rise compared to the additional indexes, according to unrefined odds that were supposed. However, QUICKI and the McAuley index can also be used to forecast risk. HOMA-IR has a better predictive% of expanding IR in PCOS persons.

Author(s) Details:

B. Gayathri,
SRM Medical College Hospital and Research Centre, SRM Institute of Science and Technology, Kattankulathur – 603203, Kanchipuram, Chennai, Tamilnadu, India.

T. Dixit Sweety Saral,
SRM Medical College Hospital and Research Centre, SRM Institute of Science and Technology, Kattankulathur – 603203, Kanchipuram, Chennai, Tamilnadu, India.

S. Aishwarya,
SRM Medical College Hospital and Research Centre, SRM Institute of Science and Technology, Kattankulathur – 603203, Kanchipuram, Chennai, Tamilnadu, India.

P. Renuka,
SRM Medical College Hospital and Research Centre, SRM Institute of Science and Technology, Kattankulathur – 603203, Kanchipuram, Chennai, Tamilnadu, India.

V. M. Vinodhini,
SRM Medical College Hospital and Research Centre, SRM Institute of Science and Technology, Kattankulathur – 603203, Kanchipuram, Chennai, Tamilnadu, India.

M. Anuradha,
Department of Obstetrics and Gynaecology, SRM Medical College Hospital And Research Centre, SRM Institute of Science and Technology, Kattankulathur – 603203, Kanchipuram, Chennai, Tamil Nadu, India.

Please see the link here: https://stm.bookpi.org/CODHR-V8/article/view/9025

Nitric Oxide Bioavailability and Insulin Resistance: An Overview | Chapter 8 | Challenges and Advances in Pharmaceutical Research Vol. 8

 

The end of this review are to discusses the mechanisms by which insulin resistance develops in the presence of increased obesity, to epitomize the causative relationship between disabled NO bioavailability and insulin resistance, and also to show the counteraccusations of life- style changes to help insulin resistance. rotundity with increased visceral obesity is an seditious condition that leads to insulin resistance. Because the insulin signalling pathway is linked to endothelial nitric oxide synthase( eNOS) activation, insulin resistance is always associated with dropped nitric oxide( NO) bioavailability. lately, accumulating substantiation has suggested that physical exercise and salutary nitrate/ nitrite diets rich in vegetables ameliorate insulin resistance by enhancing NO bioavailability, and therefore give implicit preventative and remedial options for these cases with insulin resistance.

Author(s) Details:

Jun Kobayashi,
Division of Pathophysiology, Department of Clinical Dietetics and Human Nutrition, Faculty of Pharmaceutical Science, Josai University, Saitama, Japan.

Please see the link here: https://stm.bookpi.org/CAPR-V8/article/view/8496